This led to the discovery of four G protein-coupled purinergic receptors that are elevated in cytarabine-resistant PIK3R5-low leukemia cells and stimulate PI3Kγ-PAK1 signaling that contributes to eganelisib sensitivity. Here, PIK3R5 is linked to leukemia.